+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 16Years +
All Genders
ID05734378

Prospective Study on Outcomes of Cerebral Small Vessel Disease Types and Symptoms

Led by Insel Gruppe AG, University Hospital Bern · Updated on 2023-03-08

900

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the prognosis of cerebral small vessel disease SVD, focusing on how the type of SVD and initial symptoms affect patient outcomes. This observational cohort study aims to understand the risks of different events such as strokes, hemorrhages, and cardiovascular death among patients with various forms of SVD, including hypertensive deep perforator arteriolopathy, cerebral amyloid angiopathy, and other genetic or sporadic types like CADASIL. Participants in this study are patients diagnosed with symptomatic SVD types, including those with intracerebral hemorrhage, ischemic stroke, cognitive impairment, or severe radiological signs. The study observes these patients over time without administering specific treatments, tracking clinical and radiological outcomes related to their SVD condition. During the study, participants will be monitored for events including intracerebral hemorrhage, ischemic stroke, cardiovascular death, other intracranial bleeding, neurological attacks, cognitive decline, new vascular disease onset, and functional outcomes over one year. Researchers will collect data through follow-up visits to assess these outcomes and better understand SVD progression and risks.

CONDITIONS

Brief Title

Prognosis of Cerebral Small Vessel Disease

Research Team

M

Marianne Kormann

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here